A.L. Vataire

Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease

C. Bourgier, W. Khodari, A.L. Vataire et al. · Radiotherapy and Oncology · 2010 · 72 citations

Surgical Oncology, Breast Oncology, Radiation Therapy +10

ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ Analysis

Gerold Bepler, Ken A. Olaussen, A.L. Vataire et al. · American Journal Of Pathology · 2011 · 62 citations

Situ Analysis, Advanced Lung Disease, Medicine +8

Prediction and Diagnosis of Bone Metastases in Well-Differentiated Gastro-Entero-Pancreatic Endocrine Cancer: A Prospective Comparison of Whole Body Magnetic Resonance Imaging and Somatostatin Receptor Scintigraphy

Sophie Leboulleux, Clarisse Dromain, A.L. Vataire et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 45 citations · Full text

Significance of <i>TP53</i> mutations as predictive markers of adjuvant cisplatin‐based chemotherapy in completely resected non‐small‐cell lung cancer

Xiaoli Ma, Vanessa Rousseau, Haiji Sun et al. · Molecular Oncology · 2014 · 42 citations · Full text

Adjuvant Cisplatin-based Chemotherapy, Surgical Oncology, Predictive Markers +13

Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France

Grégory Katz, Olivier Romano, Cyril Foa et al. · PLoS ONE · 2015 · 29 citations · Full text